Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coates

Showing results (511-520 of 575) with videos related to

Pageof 58
Sort By:
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
The Journal of Rheumatology|February 12, 2010
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008Laura C Coates, Dennis M McGonagle, Richard Hodgson, et al.
Arthritis Research & Therapy|January 12, 2022
Sex-specific differences and how to handle them in early psoriatic arthritisE Passia, M Vis, L C Coates, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 UpdatesYing Ying Leung, William Tillett, Ana-Maria Orbai, et al.
Annals of the Rheumatic Diseases|February 14, 2012
Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohortJohn Bowes, Pauline Ho, Edward Flynn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2024
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic ArthritisStefan Siebert, Laura C Coates, Georg Schett, et al.
The Lancet. Rheumatology|January 26, 2024
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL BalancePeter Nash, Philip J Mease, Dona Fleishaker, et al.
American Journal of Preventive Medicine|January 1, 2004
Promoting informed decisions about cancer screening in communities and healthcare systemsPeter Briss, Barbara Rimer, Barbara Reilley, et al.
Microbiology Spectrum|April 19, 2023
Associations among Milk Microbiota, Milk Fatty Acids, Milk Glycans, and Inflammation from Lactating Holstein CowsLaurynne C Coates, Sierra D Durham, David H Storms, et al.
Rheumatology (Oxford, England)|March 22, 2021
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international studyLaura C Coates, Danielle E Robinson, Ana-Maria Orbai, et al.
Pageof 58

Showing results (511-520 of 575) with videos related to

Sort By:
Pageof 58
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
The Journal of Rheumatology|February 12, 2010
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008Laura C Coates, Dennis M McGonagle, Richard Hodgson, et al.
Arthritis Research & Therapy|January 12, 2022
Sex-specific differences and how to handle them in early psoriatic arthritisE Passia, M Vis, L C Coates, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 UpdatesYing Ying Leung, William Tillett, Ana-Maria Orbai, et al.
Annals of the Rheumatic Diseases|February 14, 2012
Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohortJohn Bowes, Pauline Ho, Edward Flynn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2024
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic ArthritisStefan Siebert, Laura C Coates, Georg Schett, et al.
The Lancet. Rheumatology|January 26, 2024
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL BalancePeter Nash, Philip J Mease, Dona Fleishaker, et al.
American Journal of Preventive Medicine|January 1, 2004
Promoting informed decisions about cancer screening in communities and healthcare systemsPeter Briss, Barbara Rimer, Barbara Reilley, et al.
Microbiology Spectrum|April 19, 2023
Associations among Milk Microbiota, Milk Fatty Acids, Milk Glycans, and Inflammation from Lactating Holstein CowsLaurynne C Coates, Sierra D Durham, David H Storms, et al.
Rheumatology (Oxford, England)|March 22, 2021
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international studyLaura C Coates, Danielle E Robinson, Ana-Maria Orbai, et al.
Pageof 58